2006
DOI: 10.1016/j.vaccine.2006.06.047
|View full text |Cite
|
Sign up to set email alerts
|

Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
33
0
2

Year Published

2008
2008
2020
2020

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(35 citation statements)
references
References 33 publications
0
33
0
2
Order By: Relevance
“…This subunit vaccine was postulated to be enriched in outer membrane lipoproteins as suggested by the presence of transferrin binding lipoprotein B (TbpB) and the outer membrane lipoprotein A (OmlA) whereas periplasmic, cytoplasmic and membrane proteins were absent [20]. Vaccination of pigs with this vaccine derived from A. pleuropneumoniae apxIIA -mutants of serotypes 1, 2 and 5 showed good protective efficacy upon homologous challenge with serotype 2 and cross-protection against serotype 9 and facilitated the differentiation between infected and vaccinated animals [21]. …”
Section: Introductionmentioning
confidence: 99%
“…This subunit vaccine was postulated to be enriched in outer membrane lipoproteins as suggested by the presence of transferrin binding lipoprotein B (TbpB) and the outer membrane lipoprotein A (OmlA) whereas periplasmic, cytoplasmic and membrane proteins were absent [20]. Vaccination of pigs with this vaccine derived from A. pleuropneumoniae apxIIA -mutants of serotypes 1, 2 and 5 showed good protective efficacy upon homologous challenge with serotype 2 and cross-protection against serotype 9 and facilitated the differentiation between infected and vaccinated animals [21]. …”
Section: Introductionmentioning
confidence: 99%
“…As clear differences in virulence between serotypes have been observed, the genetic basis should be investigated at the genomic level. Here, we present the draft genome sequences of the A. pleuropneumoniae serotypes 2 (strain 4226) and 6 (strain Femo).Previous studies of different serotypes of Actinobacillus pleuropneumoniae showed that there are significant variations among them at the DNA sequence level, supposed to cause differences in pathogenicity and immunogenicity (2,8). However, it is difficult to carry out more general studies of the immunity mechanisms of different serotypes, typing-based diagnosis, and multivalent genetically engineered vaccines due to the lack of complete genome sequences of the different serotypes (11).…”
mentioning
confidence: 99%
“…Previous studies of different serotypes of Actinobacillus pleuropneumoniae showed that there are significant variations among them at the DNA sequence level, supposed to cause differences in pathogenicity and immunogenicity (2,8). However, it is difficult to carry out more general studies of the immunity mechanisms of different serotypes, typing-based diagnosis, and multivalent genetically engineered vaccines due to the lack of complete genome sequences of the different serotypes (11).…”
mentioning
confidence: 99%
“…or to confirm, that control pigs stayed A.pp .-negative until the end of the study [33]. Bacterial species diagnostic was confirmed by PCR for the ApxIIA gene and by urease activity [34,35]. …”
Section: Methodsmentioning
confidence: 99%